BI Vaccines

Discussion in 'Elanco' started by anonymous, Oct 5, 2016 at 4:01 PM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    Probably! Look at this.

    The company recorded Q3 revenues of $706.2 million. Elanco said US sales dropped 14% to $338.6m, due to wholesaler buying patterns for companion animal products and decreased revenues from food animal products caused by market access pressures.

    In the US, food animal and other products recorded Q3 sales of $234.2m (-9%) and companion animal revenues came to $104.4m (-23%).
     

  2. anonymous

    anonymous Guest

     
  3. anonymous

    anonymous Guest


    --------

    Looks as if management should have to interview for their jobs.
     
  4. anonymous

    anonymous Guest


    All while BI companion vaccine has been kicking ass, everyone's ass! Elanco needs this business to survive the "flavor of the month" flea, tick and HW business. If you're a dead beat on the Elanco team, you might be the one getting a severance check next time. Pony up, learn vaccine and have fun kicking BI's ass with their own previous product line.
     
  5. anonymous

    anonymous Guest

     
  6. anonymous

    anonymous Guest


    -----

    Sure, we are going to kick some ass, just like two years ago when we bought Novartis. Oh wait, we ended last year at -8%. And now, we are down 9% compared to last years dismal quarterly performance .
     
  7. anonymous

    anonymous Guest

    Well friend, with that attitude you've got about a year to prepare for your severance package. Good luck.
     
  8. anonymous

    anonymous Guest

    Preparing for your DM interview? You'll be great. Thinking that a positive attitude can overcome real world facts is just what being a middle manager is all about.
     
  9. anonymous

    anonymous Guest

    ----
    Any ideas on how one could get on the fast track for the severance?
     
  10. anonymous

    anonymous Guest

    You're there.